NOVN.SW SIX
Novartis AG
1W: -2.9%
1M: -11.4%
3M: -8.2%
YTD: -3.9%
1Y: +14.9%
3Y: +39.9%
5Y: +60.7%
CHF 116.34 ($140.43)
-1.72 (-1.46%)
Weekly Expected Move ±6.1%
CHF 102
CHF 109
CHF 116
CHF 123
CHF 130
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
#2
of 2
Drug Manufacturers - General
Technical Signal Map
0 Bullish
0 Neutral
2 Bearish
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| NOVN.SW Novartis AG | $221B | 21.3 | 30.3 | 16.2 | 22.7 | -0.7 | 5 | BEARISH | 14.9 |
| ROP.SW Roche Holding AG | $339B | 22.5 | 21.0 | 14.1 | 22.6 | — | 4 | BEARISH | — |
| NOVN.SW Novartis AG | $221B | 21.3 | 30.3 | 16.2 | 22.7 | -0.7 | 5 | BEARISH | 14.9 |
| ROP.SW Roche Holding AG | $339B | 22.5 | 21.0 | 14.1 | 22.6 | — | 4 | BEARISH | — |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
NOVN.SW vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F